Search - tctmd.com

Displaying 341 - 360 of 397

Sort: Relevancy | Date

News Conference News CRT 2016

Registry Behind TASTE Reopens Thrombus Aspiration Question With New Analysis of Stent Thrombosis

Shelley Wood

February 22, 2016

News Daily News

PFO Closure Faces Renewed Scrutiny in Patient-Level Meta-Analysis

Yael L. Maxwell

February 22, 2016

News Conference News ISC 2016

Neurointervention Groups Set Standards for Performing Endovascular Stroke Therapy

Todd Neale

February 16, 2016

News Daily News

Reductions in Stroke Observed With BP Less Than 140 mm Hg, Fueling Support for Lower Threshold

Michael O'Riordan

February 02, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2016

Shelley Wood

February 01, 2016

Presentation

Sleep Fragmentation, Cerebral Arteriolosclerosis, and Brain Infarct Pathology in Older People

Presenter: A.S.P. Lim

January 13, 2016

News Features

Possible Turf War Brewing Over Delivery of Acute Stroke Interventions

Todd Neale

December 28, 2015

News Daily News

Un Estudio Confirma la Rentabilidad del Dispositivo Watchman para el Cierre del AAI en el Descenso de ACV

L.A. McKeown

December 14, 2015

News Daily News

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

L.A. McKeown

December 14, 2015

News Daily News

Otro Meta Análisis Avala el Tratamiento Endovascular de los ACV Agudos

L.A. McKeown

December 01, 2015

News Daily News

Another Meta-analysis Strengthens Case for Endovascular Therapy in Acute Stroke

L.A. McKeown

December 01, 2015

News Conference News TCT 2015

RESPECT Confirms Long-term Safety, Efficacy of PFO Closure for Recurrent Stroke

Nicole Lou

October 15, 2015

News Industry News

Long-Term Study Results Show That PFO Closure May Be Effective In Preventing Recurrent Cryptogenic Stroke, Particularly In Younger Patients

October 15, 2015

News Industry News

CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

September 25, 2015

News Industry News

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

September 03, 2015

News Conference News ESC 2015

Prehospital Administration of Ticagrelor Cuts Early Ischemic Events in STEMI Patients

L.A. McKeown

September 01, 2015

News Conference News ESC 2015

Danish Registry Study Shows Potential of Stroke Risk Score in Heart Failure Patients

L.A. McKeown

August 31, 2015

News Industry News

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

August 03, 2015

Advertisement

Registry Behind TASTE Reopens Thrombus Aspiration Question With New Analysis of Stent Thrombosis

PFO Closure Faces Renewed Scrutiny in Patient-Level Meta-Analysis

Neurointervention Groups Set Standards for Performing Endovascular Stroke Therapy

Reductions in Stroke Observed With BP Less Than 140 mm Hg, Fueling Support for Lower Threshold

TCTMD’s Top 10 Most Popular Stories for January 2016

Sleep Fragmentation, Cerebral Arteriolosclerosis, and Brain Infarct Pathology in Older People

Possible Turf War Brewing Over Delivery of Acute Stroke Interventions

Un Estudio Confirma la Rentabilidad del Dispositivo Watchman para el Cierre del AAI en el Descenso de ACV

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

Otro Meta Análisis Avala el Tratamiento Endovascular de los ACV Agudos

Another Meta-analysis Strengthens Case for Endovascular Therapy in Acute Stroke

RESPECT Confirms Long-term Safety, Efficacy of PFO Closure for Recurrent Stroke

Long-Term Study Results Show That PFO Closure May Be Effective In Preventing Recurrent Cryptogenic Stroke, Particularly In Younger Patients

CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

Prehospital Administration of Ticagrelor Cuts Early Ischemic Events in STEMI Patients

Danish Registry Study Shows Potential of Stroke Risk Score in Heart Failure Patients

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content